Skip to Main Content

Author Details

Arun Swaminath
Lenox Hill Hospital
2006
81
21
PMIDPaper TitleJournal TitlePublished Year
36191274The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Am J Gastroenterol2023
37061646The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease.Int J Colorectal Dis2023
37084162Patient adverse events and technical failures with the bravo capsule pH system: insights from the MAUDE database.Esophagus2023
37278710The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis.Am J Ther2023
37144523Inflammatory bowel disease and cannabis: key counseling strategies.Curr Opin Gastroenterol2023
36895626Cannabis Use and Its Association With Thirty- and Ninety-Day Hospital Readmissions for Patients Admitted for an Inflammatory Bowel Disease Exacerbation.J Clin Med Res2023
33039584Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Clin Gastroenterol Hepatol2022
35624326Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.Dig Dis Sci2022
35416978Patient With Ulcerative Colitis and Failure of Ustekinumab Responds to Risankizumab: Similar Is Not Identical.Inflamm Bowel Dis2022
36106049A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application.Ther Clin Risk Manag2022
34532815Impatience with Inpatients: Are Hospitalization Rates Declining for IBD Patients?Dig Dis Sci2022
34015337COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.Gastroenterology2022
32696235Role of Hospital Teaching Status on Outcomes of Patients with Inflammatory Bowel Disease: A Nationwide Analysis.Dig Dis Sci2021
36777267Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions.Crohns Colitis 3602021
36776672Increased Mortality and Healthcare Costs Upon Hospital Readmissions of Ulcerative Colitis Flares: A Large Population-Based Cohort Study.Crohns Colitis 3602021
33733312Impact of inflammatory bowel disease on hospital outcomes in acute ischemic stroke: a nationwide cohort study.Int J Colorectal Dis2021
35059077<i>Clostridiodes difficile</i> Treatment Guided by Polymerase Chain Reaction Stool Testing Does not Alter Outcomes for Patients With Inflammatory Bowel Disease.J Clin Med Res2021
35059066Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19.Gastroenterology Res2021
34406140SARS-CoV-2 Immunization in Patients With Inflammatory Bowel Disease May Result in Disease Flares.Am J Gastroenterol2021
34512877Endo-hepatology: An emerging field.World J Gastrointest Endosc2021
34131784Safety of biologics in inflammatory bowel disease patients with COVID-19.Int J Colorectal Dis2021
34052278A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.Gastroenterology2021
34110607Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.Adv Ther2021
33999137Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden.J Crohns Colitis2021
32330565Donning a New Approach to the Practice of Gastroenterology: Perspectives From the COVID-19 Pandemic Epicenter.Clin Gastroenterol Hepatol2020
32062041Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.Clin Gastroenterol Hepatol2020
31671928Presentation and outcomes among inflammatory bowel disease patients with concurrent pneumatosis intestinalis: a case series and systematic review.Intest Res2020
31760611Fatigue in Inflammatory Bowel Diseases: Etiologies and Management.Adv Ther2020
33088153Review of inflammatory bowel disease and COVID-19.World J Gastroenterol2020
32656800Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.Aliment Pharmacol Ther2020
32824122The Course of SARS-COV2 Infection Was Not Severe in a Crohn's Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection.Antibodies (Basel)2020
32614051From Bad to Worse: The Relationship Between Opioid Use and Inflammatory Bowel Disease.J Crohns Colitis2020
30358848The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.Inflamm Bowel Dis2019
32582425Unusual cause of lower gastrointestinal bleed and abdominal pain.Frontline Gastroenterol2019
31050734Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.Inflamm Bowel Dis2019
30268561Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol2019
30604370Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.Dig Dis Sci2019
30625408Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.Clin Gastroenterol Hepatol2019
30312400Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.Inflamm Bowel Dis2019
28899719Hepatic Masses in a Patient With Inflammatory Bowel Disease.Gastroenterology2018
29946178Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.Am J Gastroenterol2018
29857091Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.Gastroenterology2018
29978362Management of iatrogenic perforation during colonoscopy in ulcerative colitis patients: a survey of gastroenterologists and colorectal surgeons.Int J Colorectal Dis2018
30390030Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.Am J Gastroenterol2018
30505841Increasing Pediatricians' Awareness of the Association between Anal Skin Tags and Earlier Diagnosis of Crohn's Disease.Inflamm Intest Dis2018
28489647Obesity/Bariatric Surgery and Crohn's Disease.J Clin Gastroenterol2018
29788240Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.Inflamm Bowel Dis2018
29532298The Comb Sign in Crohn's Ileocolitis.J Gen Intern Med2018
29102732A rare endoscopic finding: severely ulcerated giant sigmoid diverticulum.Gastrointest Endosc2018
27748629TNF-alpha antagonist induced lupus on three different agents.Postgrad Med2017
  • 1 - 50 of 81

Recommended Authors

Sunhee Park
University of California Irvine
Career Start Year 2014
Number of shared co-authors 4
Donevan Westerveld
New York-Presbyterian Hospital/Weill Cornell Medicine
Career Start Year 2014
Number of shared co-authors 0
Terrence C Lee
University of California San Diego
Career Start Year 2013
Number of shared co-authors 0
Gaurav Syal
university of california san diego
Career Start Year 2012
Number of shared co-authors 8
Phillip Gu
Cedars-Sinai Medical Center
Career Start Year 2012
Number of shared co-authors 4
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 2
Trilokesh D Kidambi
City of Hope National Medical Center
Career Start Year 2010
Number of shared co-authors 0
Christina Ha
Cedars-Sinai Medical Center
Career Start Year 2009
Number of shared co-authors 7
Shailja C Shah
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year 2009
Number of shared co-authors 5
Brendan Boyle
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 0
Berkeley N Limketkai
university of california los angeles School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Michael Sey
Western University
Career Start Year 2006
Number of shared co-authors 3
Daniel J Stein
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 1
Ethan A Mezoff
Nationwide Children's Hospital
Career Start Year 2005
Number of shared co-authors 0
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 2
Jenny Sauk
university of california los angeles School of Medicine
Career Start Year 2004
Number of shared co-authors 10
Elie Aoun
Columbia University
Career Start Year 2002
Number of shared co-authors 3
Gil Y Melmed
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 2001
Number of shared co-authors 10
Nimisha K Parekh
University of California Irvine
Career Start Year 2001
Number of shared co-authors 7
Uma Mahadevan
University of California San Francisco
Career Start Year 2000
Number of shared co-authors 10
Amandeep Singh
Digestive Disease and Surgery Institute, Cleveland Clinic.
Career Start Year 1998
Number of shared co-authors 5
William A Faubion
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 7
Brennan M R Spiegel
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year 1992
Number of shared co-authors 5
Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 0
Joseph A Murray
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 7
Sheryl A Pfeil
The Ohio State University College of Medicine
Career Start Year 1990
Number of shared co-authors 0
Nghia H Nguyen
University of California
Career Start Year 1990
Number of shared co-authors 7
Dermot P B McGovern
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1987
Number of shared co-authors 9
Athos Bousvaros
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 2
Phillip Fleshner
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1981
Number of shared co-authors 10

Collaborators

David Hudesman
NYU Grossman School of Medicine
Co-authored papers 14
Dana J Lukin
Jill Roberts Center for IBD
Co-authored papers 13
Sunanda V Kane
Mayo Clinic
Co-authored papers 12
William J Sandborn
University of California San Diego
Co-authored papers 12
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Co-authored papers 12
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers 12
Corey A Siegel
Dartmouth-Hitchcock Medical Center
Co-authored papers 12
Brigid S Boland
University of California
Co-authored papers 12
Parambir S Dulai
Feinberg School of Medicine Northwestern University
Co-authored papers 12
Edward V Loftus
Mayo Clinic College of Medicine and Science
Co-authored papers 12
Siddharth Singh
University of California San Diego
Co-authored papers 11
Eugenia Shmidt
University of Minnesota
Co-authored papers 11
Robert Hirten
Co-authored papers 10
Farhad Peerani
University of Alberta
Co-authored papers 5
Khadija Chaudrey
Lahey Hospital and Medical Center
Co-authored papers 5
Neeraj Narula
Farncombe Family Digestive Health Research Institute, McMaster University
Co-authored papers 5
Diana Whitehead
Dartmouth-Hitchcock Medical Center
Co-authored papers 4
Vipul Jairath
Schulich school of Medicine, Western University.
Co-authored papers 4
John T Chang
University of California San Diego
Co-authored papers 3
Ashwin N Ananthakrishnan
Co-authored papers 3
Ronghui Xu
University of California San Diego
Co-authored papers 2
Ashish Atreja
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Xiaoqian Jiang
Carnegie Mellon University, The University of Texas Health Science Center at Houston, University of California San Diego
Co-authored papers 1
Kyle Bittinger
Children's Hospital of Philadelphia
Co-authored papers 1
Richard Bonneau
Center for Computational Biology (CCB), Flatiron Institute, Simons Foundation
Co-authored papers 1
Nabeel Qureshi
RAND Corporation
Co-authored papers 1
Nahid Bhadelia
Boston University
Co-authored papers 1
Zubair Khan
University of Texas at Houston Health Science Center
Co-authored papers 1
Megan Lipcsey
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
Shuang Wang
Shanghai Putuo People's Hospital, Tongji University
Co-authored papers 1
Release 1.2